|
|
||||||||





,2
* Institut Cochin, Université Paris Descartes, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, Paris; and
Institut National de la Santé et de la Recherche Médicale U567, Cochin Hospital, Paris; and
Institut National de la Santé et de la Recherche Médicale U561, Saint-Vincent-de-Paul Hospital, Paris, France
In vivo studies have shown that regulatory CD4+ T cells regulate conventional CD4+ T cell responses to self- and environmental Ags. However, it remains unclear whether regulatory CD4+ T cells control CD8+ T cell responses to self, directly, or indirectly by decreasing available CD4+ T cell help. We have developed an experimental mouse model in which suppressive and helper T cells cannot mediate their functions. The mouse chimeras generated were not viable and rapidly developed multiple organ autoimmunity. These features were correlated with strong CD8+ T cell activation and accumulation in both lymphoid and nonlymphoid organs. In vivo Ab treatment and secondary transfer experiments demonstrated that regulatory CD4+ T cells play an important direct role in the prevention of peripheral CD8+ T cell-mediated autoimmunity.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by a grant from the French Research Ministry, a grant from the Fondation pour la Recherche Médicale, and by a grant for young investigators from the French National Research Agency. B.M. was supported by a Ph.D fellowship from the Fondation pour la Recherche Médicale.
2 Address correspondence and reprint requests to Dr. Bruno Lucas, Institut Cochin, 27 rue du Faubourg Saint-Jacques, Paris 75014, France. E-mail address: lucas{at}cochin.inserm.fr
3 Abbreviations used in this paper: BM, bone marrow; IEL, intraepithelial lymphocyte; IPEX, immune dysregulatory, polyendocrinopathy, enteropathy, X-linked.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |